| Literature DB >> 17188869 |
H Robin Heyman1, Robin R Frey, Peter F Bousquet, George A Cunha, Maria D Moskey, Asma A Ahmed, Niru B Soni, Patrick A Marcotte, Lori J Pease, Keith B Glaser, Melinda Yates, Jennifer J Bouska, Daniel H Albert, Candace L Black-Schaefer, Peter J Dandliker, Kent D Stewart, Paul Rafferty, Steven K Davidsen, Michael R Michaelides, Michael L Curtin.
Abstract
A series of substituted thienopyridine ureas was prepared and evaluated for enzymatic and cellular inhibition of KDR kinase activity. Several of these analogs, such as 2, are potent inhibitors of KDR (<10 nM) in both enzymatic and cellular assays. Further characterization of inhibitor 2 indicated that this analog possessed excellent in vivo potency (ED50 2.1 mg/kg) as measured in an estradiol-induced mouse uterine edema model.Entities:
Mesh：
Substances：
Year: 2006 PMID： 17188869 DOI： 10.1016/j.bmcl.2006.12.015
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823